Condition: HIV-1-infection · Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of the study is to evaluate the pharmacokinetics (PK), safety, tolerability, and acceptability of a long-acting injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living with HIV-1, Two to Less Than 12 Years of Age
This description comes directly from the study's public registry record.
Rachel Scheckter · (919) 321-3540 · rscheckter@fhi360.org
IMPAACT Clinicaltrials.gov Coordinator · impaact.ctgov@fstrf.org
Always discuss trial participation with your own doctor first.
| Site 5030, Emory University School of Medicine NICHD CRS | Atlanta, Georgia, United States | Recruiting |
| Site 6501, St. Jude Children's Research Hospital CRS | Memphis, Tennessee, United States | Recruiting |
| Site 12701, Gaborone CRS | Gaborone, Botswana | Recruiting |
| Site 12702, Molepolole CRS | Gaborone, Botswana | Recruiting |
| Site 5073, SOM Federal University Minas Gerais Brazil NICHD CRS | Belo Horizonte, Brazil | Recruiting |
| CRS 5071, Instituto de Puericultura e Pediatria Martagao Gesteira Clinical Research Site | Rio de Janeiro, Brazil | Recruiting |
| Site 30300 Umlazi CRS Site | Umlazi, KwaZulu-Natal, South Africa | Recruiting |
| CRS 8052, Soweto IMPAACT | Johannesburg, South Africa | Recruiting |
| Site 8051, Wits RHI Shandukani Research Centre CRS | Johannesburg, South Africa | Recruiting |
| Siriraj Hospital, Mahidol University NICHD CRS (Site #5115) | Bangkok, Bangkoknoi, Thailand | Recruiting |
| CRS 31784, Chiang Mai University HIV Treatment CRS | Chiang Mai, Thailand | Recruiting |
| Site 5116, Chiangrai Prachanukroh Hospital NICHD CRS | Chiang Rai, Thailand | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.